Por: New York Post Life January 30, 2024
A popular Attention Deficit Hyperactivity Disorder (ADHD) medication has been recalled after a different medication was found inside the packaging. Azurity Pharmaceuticals has recalled their 30-milligram dextroamphetamine sulfate tablets sold under the brand name Zenzedi. The move was made after a pharmacist in Nebraska opened a bottle to find tablets of Carbinoxamine Maleate, an antihistamine drug, mixed in with the ADHD medication, The... + full article
WPTV USA Nation January 30, 2024
Azurity Pharmaceuticals has recalled an ADHD and narcolepsy medication after the wrong pills were discovered in one of its bottles.The recall notice, which applies to a batch of Zenzedi 30 milligram tablets, came after a pharmacist in Nebraska found tablets of carbinoxamine... + más
For Some Women With ADHD, TikTok Is the First Place They Felt Heard | Time
What's Driving the Demand for ADHD Drugs Like Adderall | Time
RTTNews USA Health January 26, 2024
Azurity Pharmaceuticals, Inc. is recalling one lot of Zenzedi CII (dextroamphetamine sulfate tablets, USP) 30 mg to the consumer level, according to the U.S. Food and Drug Administration. The recall was initiated due to a mislabeled package during manufacturing. Zenzedi,... + más
ADHD medication recalled after wrong pills found in bottle | WPTV
ADHD medicine Zenzedi recalled — contains drug with opposite effect | New York Post
The Atlantic USA Health April 14, 2023
The Adderall shortage exposed a troubling gap in how doctors care for the disorder.Illustration by The Atlantic. Source: Getty.April 14, 2023, 8 AM ETIn October, when the FDA first announced a shortage of Adderall in America, the agency expected it to . But five months in, the... + más
Time USA Health April 13, 2023
For at least the last six months, Adderall—the stimulant medication commonly used to treat attention-deficit/hyperactivity disorder (ADHD)— in the U.S. That seems to be in part because demand is growing as more people are diagnosed with ADHD, a condition that can make it... + más
Op-ed: DEA and FDA rules exacerbate Adderall shortage | CNBC
Adult ADHD Is the Wild West of Psychiatry | The Atlantic
Forbes USA Business January 06, 2023
cofounder and CEO. getty Attention deficit hyperactivity disorder (ADHD) is often regarded as an inadequacy affecting one’s ability to sit still or focus for extended periods of time. However, when surveying well-known CEOs, we see that this disorder is among business leaders.... + más
Concerns grow over online ADHD diagnoses | ABC News
ABC News USA Life November 30, 2022
Approximately 10 million adults have attention-deficit/hyperactivity disorder (ADHD), according to CHADD, a respected ADHD organization founded in 1987.Now, some telemedicine services which advertise an easy path to get evaluated for a possible ADHD diagnosis and obtain a... + más
Savoring success while sidelined, Joyner Lucas can finally take his victory lap | The Boston Globe
Time USA Tech September 24, 2022
Emilie Leyes, 27, works with actors in New York to build mental resilience and manage work stress. When she started scrolling through TikToks about attention deficit hyperactivity disorder (ADHD), it was because she wanted to learn more about people with ADHD—so that she could... + más
How Women Can Manage ADHD When Anxiety Is Skyrocketing At Work | Forbes
The DEA is investigating Done over ADHD drug prescriptions | The Verge
About iurex | Privacy Policy | Disclaimer |